Your browser doesn't support javascript.
loading
Meningococcal carriage in adolescents in the United Kingdom to inform timing of an adolescent vaccination strategy.
Jeppesen, Catherine A; Snape, Matthew D; Robinson, Hannah; Gossger, Nicoletta; John, Tessa M; Voysey, Merryn; Ladhani, Shamez; Okike, Ifeanyichukwu O; Oeser, Clarissa; Kent, Alison; Oliver, Jennifer; Taylor, Pippa; Morales-Aza, Begonia; Clarke, Stuart C; Casey, Michelle; Martins, Filipa; Kitchin, Nicholas R E; Anderson, Annaliesa S; Jones, Hal; Jansen, Kathrin U; Eiden, Joseph; Pedneault, Louise; Heath, Paul T; Finn, Adam; Faust, Saul N; Pollard, Andrew J.
Afiliação
  • Jeppesen CA; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, UK. Electronic address: Catherine.jeppesen@dchft.nhs.uk.
  • Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, UK.
  • Robinson H; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, UK.
  • Gossger N; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, UK.
  • John TM; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, UK.
  • Voysey M; Primary Care Clinical Trials Unit, University of Oxford, Oxford, UK.
  • Ladhani S; Health Protection Services, Immunisation, Hepatitis and Blood Safety Department, Public Health England, 61 Colindale Avenue, London, UK.
  • Okike IO; Vaccine Institute & Paediatric Infectious Diseases Research Group, Division of Clinical Sciences, St George's, University of London, UK.
  • Oeser C; Vaccine Institute & Paediatric Infectious Diseases Research Group, Division of Clinical Sciences, St George's, University of London, UK.
  • Kent A; Vaccine Institute & Paediatric Infectious Diseases Research Group, Division of Clinical Sciences, St George's, University of London, UK.
  • Oliver J; Bristol Children's Vaccine Centre, University of Bristol, School of Cellular and Molecular Medicine and University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
  • Taylor P; Bristol Children's Vaccine Centre, University of Bristol, School of Cellular and Molecular Medicine and University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
  • Morales-Aza B; Bristol Children's Vaccine Centre, University of Bristol, School of Cellular and Molecular Medicine and University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
  • Clarke SC; Academic Unit of Clinical and Experimental Sciences, Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK; Public Health England, Southampton, UK.
  • Casey M; Southampton NIHR Wellcome Trust Clinical Research Facility, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Martins F; Southampton NIHR Wellcome Trust Clinical Research Facility, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Kitchin NR; Vaccine Research, Pfizer Ltd., Maidenhead, UK.
  • Anderson AS; Vaccine Research, Pfizer Inc., Pearl River, NY, USA.
  • Jones H; Vaccine Research, Pfizer Inc., Pearl River, NY, USA.
  • Jansen KU; Vaccine Research, Pfizer Inc., Pearl River, NY, USA.
  • Eiden J; Vaccine Research, Pfizer Inc., Pearl River, NY, USA.
  • Pedneault L; Vaccine Research, Pfizer Inc., Pearl River, NY, USA.
  • Heath PT; Vaccine Institute & Paediatric Infectious Diseases Research Group, Division of Clinical Sciences, St George's, University of London, UK.
  • Finn A; Bristol Children's Vaccine Centre, University of Bristol, School of Cellular and Molecular Medicine and University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
  • Faust SN; Academic Unit of Clinical and Experimental Sciences, Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK; Southampton NIHR Wellcome Trust Clinical Research Facility, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, UK.
J Infect ; 71(1): 43-52, 2015 Jul.
Article em En | MEDLINE | ID: mdl-25709085
OBJECTIVES: Recent development of serogroup B meningococcal (MenB) vaccines highlights the importance of pharyngeal carriage data, particularly in adolescents and young adults, to inform implementation strategies. We describe current UK carriage prevalence in this high risk population and compare methods of carriage detection. METHODS: In this multisite study, pharyngeal swabs were collected on 3-4 occasions over 6-12 months, from 1040 school and university students, aged 10-25 years. Meningococcal carriage was detected by standard culture combined with seroagglutination or PCR of cultured isolates, or by direct PCR from swab. The factor H binding protein (fHBP) variants present in meningococcal isolates were determined. RESULTS: Meningococcal serogroups B and Y were most common, with carriage up to 6.5% and 5.5% respectively, increasing throughout adolescence. Identification by seroagglutination was often unreliable, and the sensitivity of direct PCR detection was 66% compared to culture combined with PCR. Of MenB isolates, 89.1% had subfamily A variants of fHBP. The acquisition rate of MenB carriage was estimated at 2.8 per 1000 person-months. CONCLUSIONS: If vaccination is to precede the adolescent rise in MenB carriage, these data suggest it should take place in early adolescence. Studies assessing vaccine impact should use molecular methods to detect carriage.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Portador Sadio / Infecções Meningocócicas Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Humans / Male País/Região como assunto: Europa Idioma: En Revista: J Infect Ano de publicação: 2015 Tipo de documento: Article País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Portador Sadio / Infecções Meningocócicas Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Humans / Male País/Região como assunto: Europa Idioma: En Revista: J Infect Ano de publicação: 2015 Tipo de documento: Article País de publicação: Reino Unido